Evidence map›Paper›PMID 33407594›Full record

ArticleJournal of neuroinflammation2021

A novel long intergenic non-coding RNA, Nostrill, regulates iNOS gene transcription and neurotoxicity in microglia.

Nicholas W Mathy, Olivia Burleigh, Andrew Kochvar, Erin R Whiteford, Matthew Behrens, Patrick Marta, Cong Tian, Ai-Yu Gong, Kristen M Drescher, Peter S Steyger and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Research Progress on Non-coding RNAs in Cholesteatoma of the Middle Ear.Clinical and experimental otorhinolaryngology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Turmeric Extract (Molecules (Basel, Switzerland) · 2022
    Article
  17. Epigenetic Changes and Functions in Pneumoconiosis.Oxidative medicine and cellular longevity · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nicholas W MathySchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Olivia BurleighBiology Department, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0100, USA.
Andrew KochvarBiology Department, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0100, USA.
Erin R WhitefordSchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Matthew BehrensUniversity of Nebraska College of Medicine, 987020 Nebraska Medical Center, Omaha, NE, 68198-7020, USA.
Patrick MartaSchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Cong TianSchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Ai-Yu GongSchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Kristen M DrescherSchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Peter S SteygerSchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Xian-Ming ChenSchool of Medicine, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0010, USA.
Annemarie ShibataBiology Department, Creighton University, 2500 California Plaza, Omaha, NE, 68178-0100, USA. ash33271@creighton.edu.ORCID http://orcid.org/0000-0003-2451-3065
Creighton University · USNebraska Medical Center · US

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL L SORGEN · 2012 to 2026
$59.2M
NIGMS NIH HHS P20 GM103427
6 · The paper itself

Abstract

backgroundMicroglia are resident immunocompetent and phagocytic cells in the CNS. Pro-inflammatory microglia, stimulated by microbial signals such as bacterial lipopolysaccharide (LPS), viral RNAs, or inflammatory cytokines, are neurotoxic and associated with pathogenesis of several neurodegenerative diseases. Long non-coding RNAs (lncRNA) are emerging as important tissue-specific regulatory molecules directing cell differentiation and functional states and may help direct proinflammatory responses of microglia. Characterization of lncRNAs upregulated in proinflammatory microglia, such as NR_126553 or 2500002B13Rik, now termed Nostrill (iNOS Transcriptional Regulatory Intergenic LncRNA Locus) increases our understanding of molecular mechanisms in CNS innate immunity.

methodsMicroglial gene expression array analyses and qRT-PCR were used to identify a novel long intergenic non-coding RNA, Nostrill, upregulated in LPS-stimulated microglial cell lines, LPS-stimulated primary microglia, and LPS-injected mouse cortical tissue. Silencing and overexpression studies, RNA immunoprecipitation, chromatin immunoprecipitation, chromatin isolation by RNA purification assays, and qRT-PCR were used to study the function of this long non-coding RNA in microglia. In vitro assays were used to examine the effects of silencing the novel long non-coding RNA in LPS-stimulated microglia on neurotoxicity.

resultsWe report here characterization of intergenic lncRNA, NR_126553, or 2500002B13Rik now termed Nostrill (iNOS Transcriptional Regulatory Intergenic LncRNA Locus). Nostrill is induced by LPS stimulation in BV2 cells, primary murine microglia, and in cortical tissue of LPS-injected mice. Induction of Nostrill is NF-κB dependent and silencing of Nostrill decreased inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production in BV2 and primary microglial cells. Overexpression of Nostrill increased iNOS expression and NO production. RNA immunoprecipitation assays demonstrated that Nostrill is physically associated with NF-κB subunit p65 following LPS stimulation. Silencing of Nostrill significantly reduced NF-κB p65 and RNA polymerase II recruitment to the iNOS promoter and decreased H3K4me3 activating histone modifications at iNOS gene loci. In vitro studies demonstrated that silencing of Nostrill in microglia reduced LPS-stimulated microglial neurotoxicity.

conclusionsOur data indicate a new regulatory role of the NF-κB-induced Nostrill and suggest that Nostrill acts as a co-activator of transcription of iNOS resulting in the production of nitric oxide by microglia through modulation of epigenetic chromatin remodeling. Nostrill may be a target for reducing the neurotoxicity associated with iNOS-mediated inflammatory processes in microglia during neurodegeneration.

Indexed as

AnimalsCell LineCells, CulturedFemaleLipopolysaccharidesMaleMiceMice, Inbred C57BLMicrogliaNeurotoxicity SyndromesNitric Oxide Synthase Type IIRNA, Long NoncodingTranscription, GeneticLipopolysaccharidesNitric Oxide Synthase Type IINos2 protein, mouseRNA, Long Noncoding2500002B13RikInflammationiNOSlncRNALong non-coding RNAMicrogliaNeurotoxicityNF-κBNONostrillNR_126553

Identifiers

PMID33407594
PMCPMC7789650
OpenAlexW3118782702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.